US 2009/0022754 A1Published application

Recombinant antigen for diagnosis and prevention of murine typhus

AssigneeThe United States of America as represented by the Secretary of the Navy

InventorsWei-Mei Ching, Hua-Wei Chen

Life of this patent

Estimating the term…

Abstract

The invention relates to a recombinant immunogenic composition from Rickettsia typhi. The invention also relates to a method for the use of the recombinant proteins in detection and diagnostic assays and as a component in formulations for the induction of an anti-R. typhi immune response.

Claims7

Dependent claims

An immunogenic composition comprising the recombinant Rickettsia typhi OmpB polypeptide AN, or fragments thereof, with the amino acid sequence of SEQ ID No. 1.

Dependencies are inferred from the claim text.

Facts

Application: 11/881,498Filed 27 Jul 2007
Priority: 20 Apr 2006
Published: 22 Jan 2009
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

A61K 39/0233
Bacterial antigens: rickettsiales, e.g. Anaplasma
A61P 31/04
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antibacterial agents
A61P 37/04
Immunomodulators: immunostimulants
G01N 33/56911
For microorganisms, e.g. protozoa, bacteria, viruses: bacteria

Family

Application60/793,583Us provisional application · filed 20 Apr 2006
Application11/789,122Continuation in part · filed 18 Apr 2007
Application11/881,498Continuation in part
US 2007/0298047 A1Published application
US 7,544,778 B2Related patent
US 7,928,194 B2Related patent
US 2009/0022754 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results